Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM1315MO2
TNBC
Basal B
Erlotinib
EGFR
ErbB
7529.09
uM
0.33528
92.35460
-0.0364 -1.0000 0.1955 0.4723
0.6856
0.4538
SUM1315MO2
TNBC
Basal B
Erlotinib
EGFR
ErbB
7528.091
uM
8.38320
144.72550
0.0444 -1.0000 0.3857 0.2376
0.9011
0.9421
SUM1315MO2
TNBC
Basal B
Erlotinib
EGFR
ErbB
10381.092
uM
19.61830
284.84140
0.3667 -1.0000 0.4106 0.1427
0.9356
1.4137
SUM1315MO2
TNBC
Basal B
Erlotinib
EGFR
ErbB
9044.091
uM
6.14760
85.37030
0.0264 -1.0000 0.4176 0.2321
0.9590
0.6432
SUM1315MO2
TNBC
Basal B
Etoposide
TOP2
TOP
9044.074
uM
0.14874
0.57237
-0.8205 -0.7290 0.6674 0.8246
0.9586
0.6607
SUM1315MO2
TNBC
Basal B
Etoposide
TOP2
TOP
7528.074
uM
0.45241
3.38780
-0.6798 -0.8278 0.4851 0.6555
0.9682
1.0143
SUM1315MO2
TNBC
Basal B
Everolimus
MTOR
MTOR
12428.164
uM
0.44818
6.51110
-0.9897 -1.0000 0.4105 0.5040
0.7797
0.8332
SUM1315MO2
TNBC
Basal B
Everolimus
MTOR
MTOR
10875.156
uM
0.08047
2.12030
-1.0000 -1.0000 0.3358 0.6358
0.8196
0.4392
SUM1315MO2
TNBC
Basal B
Fascaplysin
CDK4
CDK
7528.084
uM
0.41330
0.86388
-0.9745 -1.0000 1.4901 0.5789
0.9968
1.0247
SUM1315MO2
TNBC
Basal B
Fascaplysin
CDK4
CDK
9044.084
uM
0.42073
0.52412
-0.9998 -1.0000 5.0000 0.6077
0.9987
0.4769
SUM1315MO2
TNBC
Basal B
FR180204
ERK1/2
MAPK
10875.149
uM
13.45520
39.12590
0.0664 -1.0000 1.0292 0.1281
0.9415
0.7469
SUM1315MO2
TNBC
Basal B
FR180204
ERK1/2
MAPK
12428.166
uM
23.54840
23.91770
0.1484 -0.0092 1.1773 0.1309
0.9451
0.8223
SUM1315MO2
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12428.167
uM
116.70050
998.9280
0.5788 -0.7604 0.4306 0.0955
0.9109
1.0169
SUM1315MO2
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10875.154
uM
32.91020
9.61220
0.4999 0.4988 4.8953 0.0149
0.9436
0.7163
SUM1315MO2
TNBC
Basal B
Gefitinib
EGFR
ErbB
9797.019
uM
0.32507
1.57910
-0.8809 -1.0000 0.6951 0.5248
0.9594
0.4912
SUM1315MO2
TNBC
Basal B
Gefitinib
EGFR
ErbB
7529.016
uM
4.92220
27.16080
-0.0638 -1.0000 0.6432 0.2152
0.9605
0.5847
SUM1315MO2
TNBC
Basal B
Geldanamycin
HSP90
HSP90
9797.012
uM
0.00490
0.00788
-0.5647 -0.5372 1.5343 1.1171
0.9868
0.4792
SUM1315MO2
TNBC
Basal B
Geldanamycin
HSP90
HSP90
10139.012
uM
0.06192
0.07685
-0.1379 -0.1873 1.4722 0.6549
0.9926
0.8556
SUM1315MO2
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
9797.011
uM
0.07699
5.79710
-0.4438 -1.0000 0.2542 0.6732
0.9193
0.5004
SUM1315MO2
TNBC
Basal B
Glycyl-H-1152
ROCK2
12428.169
uM
10.22690
8.44450
0.2193 0.0693 0.7792 0.1895
0.9241
0.7851
SUM1315MO2
TNBC
Basal B
Glycyl-H-1152
ROCK2
10875.15
uM
4.09610
11.30940
-0.1016 -0.5895 0.7669 0.2116
0.9744
0.8527
SUM1315MO2
TNBC
Basal B
GSK1070916
AURK
AURK
10139.001
uM
1.52610
5.13290
-0.7348 -1.0000 0.9057 0.3315
0.9948
0.7336
SUM1315MO2
TNBC
Basal B
GSK1070916
AURK
AURK
9797.001
uM
0.93105
2.25530
-0.9738 -1.0000 1.2418 0.4123
0.9950
0.6012
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7529.09
uM
inf
inf
0.1997 0.1997 0.0000 0.5313
0.5381
0.4538
SUM1315MO2
TNBC
Basal B
GSK1838705A
IGF1R
RTK
9044.098
uM
1.1170
0.91442
-0.5477 0.1026 1.1475 0.3428
0.5871
0.8807